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Methods: From 07/94 to 10/01 the NRMI accrued 3,768 pts with AMI complicated by CS
from 980 hospitals without PTCA/CABG capability. Trends in baseline characteristics, in-
hospital mortality, transfer rates to hospitals with PTCA/CABG capability, and manage-
ment patterns were evaluated.
Results: The mean age of the group was 71.3 + 12.5 years. There were no differences
over time in age, % women, stroke, and prior CABG. There were fewer pts in recent
years with history of MI (p<0.001), but more pts with prior PTCA, CHF, HTN and dyslipi-
demia (p<0.05). There was a trend of reduction in use of FT from 39.5% to 31.4%
(p=0.05), and very low rates of IABP use that did not change over time (5.7% to 5.3%, p=
N.S.). Mortality was very high and unchanged over time (84.5% to 85.2%, p=N.S.). Over-
all transfer-out rates increased (p<0.0001) from 27.7% to 33.9%. However, transfer-out
rates remained relatively flat over last 4 years (32.7%, 33.3%, 34.8%, 33.9%, respec-
tively), with mortality rates increasing over that time period (81.2%, 83.9%, 85.3%,
85.9%, respectively), but FT rates continued to decrease (36.2%, 38.2%, 36%, 31.4%,
respectively).
Conclusion: FT and IABP were underutilized in hospitals without PTCA/CABG capabil-
ity. Mortality was very high and unchanged over time. Furthermore, FT utilization was
decreasing despite the fact that transfer out rates remained unchanged over the last sev-
eral years. Overall, most registered pts did not receive FT or IABP, and were not trans-
ferred out to hospitals with PTCA/CABG capability. For hospitals without PTCA/CABG
capability we recommend an early FT and IABP, followed by immediate transfer to
regional centers for revascularization for patients < 75 years of age.
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1116-10 Shock in Patients With Acute Aortic Dissection: Clinical 
Characteristics, Risk Factors, and Outcomes
Thomas T. Tsai, Eric M. Isselbacher, Christoph A. Nienaber, Arturo Evangelista, 
Jianming Fang, Dean E. Smith, Jeanna V. Cooper, Stuart Hutchison, Eduardo Bossone, 
Patrick O'Gara, Kim A. Eagle, Rajendra H. Mehta, On behalf of the International Registry 
of Acute Aortic dissection, University of Michigan, Ann Arbor, MI
Background: Shock often complicates acute aortic dissection (AAD). However, the clini-
cal characteristics, risk factors and outcomes of shock in patients with AAD are not
known. Methods: Accordingly, we studied 1073 AAD patients enrolled in the Interna-
tional Registry of Acute Aortic Dissection (IRAD) between 1996 and 2001. Results:
Shock occurred in 313 (29.2%) AAD patients (46.0% on admission and in the remaining
after admission) and was more common in patients with acute type A than type B dissec-
tion (37.9% vs. 14.6%, p<0.0001). The proportion of patients with shock increased with
advancing age (p for trend =0.043). Multivariate logistic regression identified age >70
years (OR, 2.0; 95% CI, 1.4-2.9; P<0.0001), type A dissection (referent type B AAD, OR
2.1, 95% CI, 1.4-3.2, p=0.0002), neurologic deficit (OR 3.8; 95% CI, 2.2-6.6; P<0.0001),
syncope (OR 2.9; 95% CI, 1.8-4.7; P<0.0001), aortic regurgitation requiring valve sur-
gery (OR 1.9, 95% CI 1.1-3.3, P=0.024), cardiac tamponade (OR 5.1, 95% CI 3.0-8.8,
P<0.001) and new Q wave or ST segment deviation on ECG (OR 1.6; 95% CI, 1.1-2.4;
P=0.014) as independent associations of shock (c-statistic 0.78, Hosmer Lemeshow χ2
5.78, degrees of freedom 8, p=0.67). To validate our model and examine its ability to dis-
criminate, we used the bootstrap resampling technique, and calculated the ROC curves
of 1000, 100% samples of data with replacement. The area under the average curve was
0.79 (95% CI 0.75 to 0.82), indicating a good ability of the model to discriminate between
patients with AAD who had shock and those who did not. Hospital complications (neuro-
logical deficits [22.7% versus 12.0%], altered mental status [26.1% versus 4.4%], myo-
cardial [14.6% versus 6.9%], mesenteric [6.9% versus 2.6%] or limb ischemia [14.6%
versus 6.9%]); and death [55.0% versus 10.3%] occurred more frequently in patients with
shock than in those without it (P<0.001 for all comparisons). Conclusions: Shock
occurred in more than a quarter of AAD patients and was associated with a much higher
in-hospital adverse event rate. Our study identified factors associated with shock in AAD
patients. Knowledge of these associations may be useful to clinicians as they triage and
treat patients with AAD.
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1116-11 The Mineralocorticoid Paradox: Profibrotic In Vivo in 
Experimental Asymptomatic Left Ventricular 
Dysfunction but Antifibrotic In Vitro
Lisa C. Costello-Boerrigter, Guido Boerrigter, Gail J. Harty, Alessandro Cataliotti, Denise 
M. Heublein, Sharon M. Sandberg, John A. Schirger, Fernando L. Martin, Margaret M. 
Redfield, John C. Burnett, Jr., Mayo Clinic and Foundation, Rochester, MN
Background: Asymptomatic left ventricular dysfunction (ALVD) has maintenance of
sodium (Na) excretion and activation of natriuretic peptides (NP), but not aldosterone
(ALDO). Normal subjects escape the Na and water retaining effects of exogenous deoxy-
corticosterone acetate (DOCA), an ALDO precursor. Overt congestive heart failure
(CHF) cannot escape ALDO or DOCA's actions, resulting in worse edema. ALDO may
cause cardiac hypertrophy and fibrosis. In clinical trials ALDO antagonism benefited CHF
patients perhaps due to antifibrotic effects. ALVD’s response to DOCA excess is
unknown. We hypothesized that: (1) in ALVD exogenous DOCA would result in Na and
fluid retention, (2) DOCA excess in ALVD would give cardiac fibrosis, and (3) collagen
synthesis would increase in cardiac fibroblasts (CF) incubated with ALDO.
Methods: Cardiorenal function was assessed in two groups of ALVD dogs induced by
180 bpm tachypacing. One group was a control (A); the other (A+D) received DOCA (1
mg/kg/d i.m.) starting pacing day 2. Collagen area fraction was measured in picrosirius
red stained left ventricle. The effect of ALDO (10-9 M, 10-6 M) on DNA and collagen syn-
theses in canine CF from normal left ventricle was determined by [3H]-thymidine and
[3H]-proline incorporation.
Results: Urinary flow (UVolR) and Na excretion (UNaV) were unchanged in A, with no
ALDO activation. In contrast, in A+D UNaV decreased the first two days DOCA was
given, but normalized on day 4 despite continuing DOCA. Increased UVolR and urinary
cGMP excretion occurred with DOCA escape. No differences in cardiorenal parameters
existed on day 11. Collagen area fraction in A+D was significantly higher than in A,
3.6±0.4% vs 2.0±0.2% (p=0.02). Conversely, ALDO (10-6M) added to CF decreased
[3H]-proline and [3H]-thymidine incorporation (both p<0.01).
Conclusion: ALVD escapes DOCA’s Na retaining effects. Despite A+D’s renal escape,
this group had more cardiac fibrosis than A. Hence, the heart did not escape DOCA’s tis-
sue effects. However, ALDO failed as a direct stimulator of collagen synthesis in CF. This
paradox of mineralocorticoid induced fibrosis in vivo but not in vitro suggests that ALDO’s
profibrotic effects require another factor’s presence.
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1116-12 PG-530742, a Novel Matrix Metalloproteinase Inhibitor, 
Improves Left Ventricular Function and Attenuates 
Remodeling in Dogs With Chronic Heart Failure
Hani N. Sabbah, Hideaki Morita, George Suzuki, Victor G. Sharov, Anastassia Todor, 
Timothy P. O'Neill, Henry Ford Health System, Detroit, MI, Procter and Gamble 
Pharmaceuticals, Mason, OH
Background: PG-530742 (PG) is a hydroxamic-based matrix metalloproteinase (MMP)
inhibitor that is 2 to 3 orders of magnitude more potent as an inhibitor of MMP-2, -3, -8, -
9, -13 and -14 than MMP-1 and -7. This study examined the effects of chronic monother-
apy with PG on LV function and remodeling in dogs with coronary microembolization-
induced heart failure (HF). Methods: A blinded, randomized, placebo-controlled design
was used. Dogs were randomized to 3 months therapy with low dose (LD) PG (0.2 mg/
kg, tid, n=8), high dose (HD) PG (3.5 mg/kg, tid, n=8) or placebo (PL) (vehicle, tid, n=8).
LV ejection fraction (EF), end-diastolic (EDV) and end-systolic volumes were measured
from ventriculograms at time of randomization (PRE) and after 3 months of therapy
(POST). At POST, hearts were removed and LV tissue used to measure cardiomyocyte
cross-sectional area (MCSA), a measure of myocyte hypertrophy and volume fraction of
interstitial fibrosis (VFIF). Results: In PL-treated dogs, EDV and ESV increased and EF
decreased (Table). LD-PG elicited changes similar to PL. In contrast, HD-PG decreased
EDV and ESV and increased EF. MCSA was not different with LD-PG compared to PL
(737 ± 28 vs 688 ± 26 um2) but decreased with HD-PG (498 ± 22 um2, P<0.05). VFIF
was not different with LD-PG compared to PL (15 ± 1 vs 14 ± 1 %) but decreased with
HD-PG (10 ± 1 %, P<0.05). Conclusions: In dogs with HF, chronic therapy with HD-PG
improves LV function and attenuates LV remodeling. PG may be useful as adjunct ther-
apy for treatment of chronic HF.
Noon
1116-13 Chronic Therapy With Eplerenone Reduces Tubulin-
Alpha and -Beta mRNA Expression and Increases Titin 
mRNA Expression in Dogs With Heart Failure
Sharad Rastogi, Sudhish Mishra, Ramesh Gupta, George Suzuki, Hideaki Morita, Sidney 
Goldstein, Hani N. Sabbah, Henry Ford Health System, Detroit, MI
Background: Titin, a cytoskeletal protein that ensures elasticity and extensibility of the
sarcomere is decreased in heart failure (HF) leading to increased LV stiffness. Tubulin
(TU), a cytoskeletal protein consisting of an alpha and a beta isoforms increases in HF
and can lead to contractile dysfunction and loss of compliance. We previously showed
that eplerenone (EPL), a new aldosterone receptor blocker, reduces LV end-diastolic wall
stress, stiffness and improves relaxation in dogs with HF. This study examined the effects
of EPL on titin and TU-alpha and -beta mRNA expression in LV tissue of dogs with coro-
nary microembolization-induced HF. Methods: Dogs were randomized to 3 months ther-
apy with EPL (10 mg/kg Bid, n=7) or to no therapy (control, n=7). Tissue from 6 normal
(NL) dogs was used for comparison. LV tissue from all dogs was used to extract RNA.
mRNA expression for titin and TU was measured using reverse transcriptase polymerase
chain reaction and bands quantified in densitometeric units. Results: Data shown in
table. Compared to NL, titin mRNA expression decreased in controls and returned to
near NL with EPL. mRNA expression for TU-alpha and -beta increased in controls com-
pared to NL and returned to near NL with EPL. Conclusions: In dogs with HF, mRNA
expression for titin is decreased and mRNA expression for TU-alpha and -beta is
increased. EPL therapy normalized expression of both genes. This restoration of key
cytoskeletal proteins partly explains the improvement in LV diastolic function seen with
EPL.
Placebo LD-PG-530742 HD-PG-530742
PRE POST PRE POST PRE POST
EDV (ml) 57 + 2 63 + 2* 58 + 2 63 + 2* 59 + 4 57 + 4*
ESV (ml) 36 + 1 42 + 2* 38 + 2 43 + 2* 38 + 2 34 + 2*
EF (%) 36 + 1 33 + 1* 35 + 1 31 + 1* 36 + 1 40 + 1*
*=p<0.02 PRE vs. POST
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1116-14 Three-Dimensional Analysis of Cardiac Magnetic 
Resonance Imaging the Using Spherical Harmonics 
Model
Heng Huang, Justin Pearlman, Li Shen, Ling Gao, Fillia S. Makedon, Dartmouth Medical 
School, Hanover, NH, Dartmouth College, Hanover, NH
Background: Dilated left ventricular (LV) systolic dysfunction exhibits shape changes of
the LV. There is progressive remodeling, and that remodeling follows different patterns.
Therefore we investigated the role of computer modeling of the 3-D shape changes
observed by cardiovascular magnetic resonance (CMR).
Method: CMR scans were performed in 47 subjects; 5 subjects had normal chamber
dimensions and systolic function (EF>55%) and 42 subjects had dilated cardiomyopathy.
MR imaging was performed on a 1.5T scanner (GE Excite). We developed an integrated
framework for the global measurement and analysis of 3-D motion of the heart with the
potential extension to disease classification based on heart behaviors. We adapted
spherical harmonics (SPHARM) expansion techniques to create the shape descriptions
for each closed 3-D heart surface.
Result: SPHARM shape modeling for functional analysis reliably distinguished normal
hearts from dilated cardiomyopathy. Standard parameters of RV and LV functions SV, EF,
LVM and WT were computed on the model vs. original data with error<3%. Based on the
shape model, we created a user-friendly interactive program to manipulate 3-D represen-
tations of SPHARM. The animation components generate the 3-D motions, and aid visual
inspection of various dynamic behaviors.
Conclusion: SPHARM shape modeling techniques offer new insights in cardiac functional
analysis for studying remodeling due to dilated cardiomyopathy.
Fig.1: Coefficients up to degrees 1, 2, 5, and 16.
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1116-15 Using the Maturing Veterans Affairs Multimedia 
Electronic Patient Record to Achieve Measurable 
Improvements in Patient Care
Ross D. Fletcher, Ruth E. Dayhoff, Amanda C. Graves, Chiao M. Wu, Kevin Crawford, 
Christopher D. McManus, Ronald E. Jones, Department of Veterans Affairs Medical 
Center, Washington, DC, Georgetown University Medical Center, Washington, DC
Background: Using the VA multimedia electronic patient record (EPR) has significantly
improved patient care at the Washington DC VA Medical Center. Using the EPR, a cardi-
ologist can review and manage the entire patient record using a GUI based patient chart,
with all diagnostic images, including ECGs, and cine loops. The EPR improves patient
care by a eliminating paperwork and streamlining non-clinical tasks that reduce effi-
ciency. Methods: All aspects of the clinical record are distributed through a fiber optic
backbone, then by 10/100 Mbyte distribution system to each of over 1500 workstations.
DICOM images and screen captures are sent to a 2.5 Terabyte server and archived to a
9 Terabyte Jukebox. ECGs are read directly from the MUSE ECG server using a custom
interface. Cardiology images include echoes, coronary arteriograms, ventriculograms,
MUGA, thallium studies, X-rays, and ECG tracings, as well as other multispecialty
images. The Cardiology database includes records of over 7,818 Caths; 7,770 Holters;
87,079 ECGs; 24,496 Echocardiograms; 11,985 ETTs; and 2,082 EPs. Results: All
reports, notes, orders, and discharge summaries are written directly into the patient
record. The hospital is >98% paperless and filmless. Since the database is complete, it
can be mined to provide reminders and schedule procedures by diagnoses, problem list
or directives. Despite national trends, patients with hypertension, hypercholesterolemia,
diabetes, and CHF have shown progressive improvement with this system. The hyper-
tensive patient population has shown a 63% improvement in patients returning to normal
(p > 0.0001). LDL > 120 post MI has shown a 21% improvement. Similar improvements
are being made in the other cardiological disease.Conclusions: Clinicians have a tool
that provides patient information, enhances their productivity by eliminating paperwork,
reduces the time spent in non-patient endeavors, and by creating and scheduling remind-
ers and procedures - improves patient care.
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1116-16 Electronic Clinical Reminders Effectively Identify 
Patients Not Meeting Guidelines
Jason H. Cole, C. Yvette Williams, James Grant, David C. Ziemer, Claudine Jurkovitz, 
William S. Weintraub, Emory University, Atlanta, GA, Atlanta Veterans Affairs Medical 
Center, Atlanta, GA
Background: There has been significant interest in the use of computerized medical
systems to improve quality of care. The Veterans Administration (VA) Healthcare System
has developed a comprehensive electronic medical record, and the Computerized
Patient Record System (CPRS) has a tool called Clinical Reminders to assist physician
performance. However, these reminders have not been fully developed into decision sup-
port tools. Methods: National NCEP-ATP III Cholesterol Guidelines and JNC-7 Hyper-
tension guidelines were used as the basis for the creation of a clinical algorithm for
comprehensive lipid and hypertension management at the Atlanta VA. Multiple clinical
reminders were created so that high, intermediate, and low-risk patients could be
described. Reminders identified individuals not meeting published guidelines. Results:
Only 51.1% (n=8534) of all high-risk patients seen since 1997 met national cholesterol
guidelines, and only 35.0% (n=6796) of all patients with visits since January 2003 had
normal blood pressure per JNC-7 guidelines. 18.2% (n=3531) of patients had “prehyper-
tension.” 18.9% (n=3664) had Stage I hypertension, and 28.0% (n=5431) suffered Stage
II hypertension. Clinical reminders effectively identified these patients and provided guid-
ance to physicians to institute medical therapy. Conclusion: Computer-based reminders
in the VA CPRS system can effectively identify patients not meeting national guidelines
and can make specific recommendations to change therapy. 
Noon
1116-17 The Combined Impact of Metabolic Syndrome and 
Physical Inactivity on Subclinical Atherosclerosis in the 
Asymptomatic Population
Milind Y. Desai, Khurram Nasir, John A. Rumberger, Joel B. Braunstein, Matthew J. 
Budoff, Wendy S. Post, Roger S. Blumenthal, Johns Hopkins University, Baltimore, MD
Background: Lack of sufficient physical activity (PA), metabolic syndrome (MS) and sub-
clinical atherosclerosis (SA) increase risk of developing CHD. The combined effect of MS
and lack of PA on SA is not well defined. We determined whether combination of MS and
lack of PA increases prevalence of SA in asymptomatic individuals. Methods: After
excluding diabetics (n = 413), we studied 6142 individuals (67 % males, mean age 52 ± 9
years) referred for electron beam tomography. MS was defined as hypertension (blood
pressure > 130/85 mm Hg), hypertriglyceridemia > 150 mg/dl, HDL < 40 mg/dl, and body
mass index > 30 kg/m2 (subjects meeting > 2 criteria were included). PA was defined as
self-reported exercise regimen of any duration. Patients were divided into 4 groups: 1 (n
= 302) = (+)MS/(-) PA, 2 (n = 471) = (+)MS/(+)PA, 3 (n = 1068) = (-)MS/(-)PA and 4 (n =
3521) = (-)MS/(+)PA. Abnormal coronary artery calcification (ACAC) or significant SA
was defined as calcium score > 75th percentile based on gender and age. Results:
ACAC was present in 30 % patients in Group 1, 25 %patients in Group 2 and 22 %
patients in Group 3 and 16 % patients in Group 4 with an abnormal CAC (figure). Group
1 patients had 53 % greater prevalence of ACAC than group 4 subjects (p< 0.001).
These results applied to both genders. Conclusion: In an asymptomatic population,
combination of MS and lack of PA is associated with an incremental increase in preva-
lence of SA. PA in subjects with MS is associated with lower prevalence of SA, similar to
levels observed in non-MS subjects.
NL HF-Control HF + EPL
Titin (du) 170 +  6 117 + 5* 141 +  7**
Tubulin-alpha (du) 53 + 2 77 + 1* 42 + 7**
Tubulin-beta (du) 37 +  4 80 +  3* 54 +  4**
*=p<0.05 vs. NL; **=p<0.05 vs. HF-Control
